Trial Profile
An Open Label Phase 4 Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2013
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 08 May 2008 New trial record.